Related Experiment Video
Updated: May 24, 2025

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes
Matthew J Carpenter1,2,3, Tracy T Smith1,3, Kyle J Walters4
1Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, SC, USA.
Introduction:
The pattern and trajectory of dual use are critical to differentiating it as a health benefit versus harm.
Methods:
Based within a large, naturalistic randomized controlled trial of e-cigarette in the United States, adults who smoke were given a 1-month sample of tank-style e-cigarette to use as they wish (n = 427) or not (n = 211). Analyses are restricted to participants from the e-cigarette group who became dual users by one month (DU; n = 315) versus participants in control group who exclusively used combustible cigarettes (EUCC; n = 182). Primary outcomes are based on changes in combustible cigarette smoking (cigarettes per day; CPD) across daily diaries within sampling period, and at 3- and 6-month follow-up.
Results:
DUs reported significantly more diary days of large smoking reduction (smoking 1-50% of baseline CPD: 23.1% of all diary days) and not smoking (5.6% of all diary days) than did EUCCs (6.8% and 1.4%, respectively) during sampling period (ps < .001). Among DUs, 18.4% reported smoking 1-50% of baseline CPD and 9.5% were not smoking at Week 12; 17.5% reported smoking 1-50% of baseline CPD and 9.2% were not smoking at Week 24. In contrast, among EUCCs, 7.1% reported 1-50% of baseline CPD at Week 12 and 1.7% were not smoking. At Week 24, 8.2% reported 1-50% of baseline CPD and 7.1% were not smoking. Among DUs, e-cigarette use days were associated with greater probability of non-smoking days (8%) than non-e-cigarette use days (3%, p < .001).
Conclusion:
Compared to continued cigarette smoking, initiating dual use reduced smoking and increased cigarette-free days.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...